Trial Profile
A multi-institutional phase II trial to evaluate temozolomide in children with recurrent medulloblastoma/primitive neuroectodermal tumor.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Medulloblastoma; Primitive neuroectodermal tumours
- Focus Therapeutic Use
- 24 Nov 2015 New trial record